The effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: systematic review, network meta-analysis and health economic evaluation.

While this showed a trend favouring nintedanib, it was not statistically significant and should be interpreted with caution until such time that a more complete analysis can be undertaken on more robust data.

also in 53,322 other papers